Choice of human plasma preparations for transfusion

Transfusion Medicine Reviews

Volumn 13, Issue 2, 1999, Pages 84-88

  Bianco, C ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DETERGENT; FRESH FROZEN PLASMA; PROCOAGULANT; SOLVENT;

BLOOD TRANSFUSION REACTION; DISEASE TRANSMISSION; MEDICAL DECISION MAKING; PLASMA TRANSFUSION; RISK; SHORT SURVEY;

EID: 0033005914     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(99)80002-9     Document Type: Article

References (17)

1. Klein HG Dodd RY Dzik WH Committee Report: Current status of solvent/detergent-treated frozen plasma Transfusion 38 1998 102 107
2. Circular of Information for the Use of Human Blood and Blood Components April 1997 AABB, ABC, ARC
3. ®+SD. Manufactured by V.I. Technologies, Inc. (VITEX), 155 Duryea Rd, Melville, NY 11747; FDA License No. 386. Distributed by American Red Cross, Blood Services, Washington, DC 20006.
4. Horowitz B Inactivation of viruses found in plasma proteins Goldstein J Biotechnology of Blood 1991 Butterworth-Heinmann Boston, MA 417 430
5. College of American Pathologists Practice parameter for the use of fresh-frozen plasma, cryoprecipitate and platelets JAMA 271 1994 777 781
6. Moake J Chintagumpala N Turner P Solvent/detergent plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura Blood 84 1994 490 497
7. Popovsky MA Moore SB Diagnostic and pathogenetic considerations in transfusion related acute lung injury Transfusion 25 1985 573 576
8. Schreiber GB Busch MP Kleinman SH The risk of transfusion transmitted viral infections N Engl J Med 334 1996 1685 1690
9. Mannucci PM Gdovin S Gringeri A Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group Ann Intern Med 120 1994 1 7
10. McOmish F Yap PL Jordan A Detection of parvovirus B19 in donated blood: A model system for screening by polymerase chain reaction J Clin Microbiol 31 1993 323 328
11. Zanella A Rossi F Cesana C Transfusion transmitted human parvovirus B19 infection in a thalassemic patient Transfusion 35 1995 769 772
12. Protection against viral hepatitis Recommendations of the Immunization Practices Advisory Committee (ACIP) MMWR 39 1990 2 26
13. Kurtzman GJ Cohen BJ Field AM Immune response to B19 parvovirus and an antibody defect in persistent viral infection J Clin Invest 84 1989 1114 1123
14. Ragni MV Koch WC Jordan JA Parvovirus B19 infection in patients with hemophilia Transfusion 36 1966 238 241
15. Lynch TJ Weinstein DL Tankersley JC Considerations of pool size in the manufacture of plasma derivatives Transfusion 36 1996 770 775
16. Lee DH Paling JE Blajchman MA A new tool for communicating transfusion risk information Transfusion 38 1998 184 188
17. Aubuchon JP Birkmeyer JD Safety and cost-effectiveness of solvent-detergent treated plasma JAMA 272 1994 1210 1214